Parathyroid Carcinoma

Parathyroid Carcinoma, explained simply

Everything a patient or caregiver wants to understand: what parathyroid carcinoma is, how doctors describe its stage, the standard treatment plan, how radiation works, and the research shaping care today.

On this page

Watch: the CureRays® explainer series

Watch Dr. Hess explain radiation therapyPlain-language videos on how radiation works, what treatment feels like, and what to expect — on the CureRays® YouTube channel.

Prefer to read? The full guide below is complete on its own, with tables you can revisit any time.

What is parathyroid carcinoma?

Parathyroid carcinoma is a very rare cancer of the parathyroid glands — four tiny glands behind the thyroid in the neck that make parathyroid hormone (PTH), which controls the level of calcium in the blood. Almost all parathyroid carcinomas are 'functioning,' meaning they pour out PTH and drive blood calcium to dangerously high levels. Most of the symptoms — kidney stones, bone pain and fractures, fatigue, confusion, and stomach upset — come from this severe high calcium rather than from the tumor pressing on anything. Because the cancer grows slowly but the high calcium can be life-threatening, controlling calcium is an urgent priority alongside treating the tumor itself. The single most important treatment is a complete surgical removal of the tumor together with the surrounding tissue in one piece (en-bloc resection) during the first operation, because that offers the best chance of cure and recurrences are hard to clear later. Some cases are linked to an inherited condition called hyperparathyroidism-jaw tumor syndrome, tied to the CDC73 (HRPT2) gene.

In one line: Parathyroid carcinoma is a very rare cancer of one of the tiny neck glands that control calcium — most of its harm comes from sky-high calcium levels, and the best chance of cure is complete removal in one careful operation.

The main types

Doctors group parathyroid carcinoma by where it starts and how it behaves:

TypeWhat it means, simply
Functioning parathyroid carcinomaBy far the most common form; it overproduces parathyroid hormone, causing very high blood calcium that drives most symptoms and complications.
Non-functioning parathyroid carcinomaExtremely rare; it does not raise calcium, so it tends to be found later as a neck mass, which can make it harder to manage.

Staging, in plain terms

Unlike most cancers, parathyroid carcinoma does not have a widely used formal TNM stage. What matters most is whether the tumor was completely removed in one piece at the first surgery, whether it has invaded nearby structures, and whether it has spread to lymph nodes or distant organs. The blood calcium and PTH levels are followed closely as markers of disease.

No standard TNM; risk based on completeness of removal and spreadWhat it generally means
Localized, fully removedTumor confined to the gland and taken out completely in one piece at the first operation — the situation with the best chance of long-term cure.
Locally invasive or incompletely removedTumor has grown into nearby tissue (such as the thyroid or nearby nerve) or could not be fully removed, raising the risk of recurrence.
Regional spreadSpread to lymph nodes in the neck. Managed with more extensive surgery and close calcium control.
MetastaticSpread to distant sites such as the lungs, bones, or liver. Treated with surgery to remove deposits when possible, plus medicines to control calcium long-term.
Plain-language takeaway: Staging tells your team how much disease there is and where — but your tumor's biology matters too. Two people described the same way can still have different plans, and that's a good thing.

The standard of care

Parathyroid Carcinoma is almost always treated by a team that may include a surgeon, a medical oncologist, and a radiation oncologist, combining therapies for the best result. The usual building blocks are:

Complete en-bloc surgery (the key to cure)

Removing the tumor together with the nearby thyroid lobe and any involved tissue in one piece at the first operation — without rupturing it — offers the best chance of cure and is the single most important step.

Controlling high calcium

Before and after surgery, high blood calcium is treated urgently with fluids and medicines (such as bisphosphonates and the drug cinacalcet, which lowers PTH-driven calcium) to protect the kidneys, heart, and brain.

Re-operation for recurrence

Because this cancer comes back locally or as isolated deposits, repeat surgery to remove recurrent tumor is often the most effective way to regain calcium control and prolong life.

Calcium and PTH monitoring

Blood calcium and PTH are followed long-term as sensitive markers — a rising level can reveal recurrence before it is visible on scans.

How radiation treatment works

Radiation damages the DNA inside cancer cells so they can no longer divide and survive, while normal cells are better at repairing themselves. For parathyroid carcinoma, surgery is the main cure, and radiation is used in a supporting role — given to the neck after surgery to lower the chance the cancer comes back when it was invasive or incompletely removed, or to ease symptoms from disease that has spread. It is delivered as short, painless daily sessions and leaves no radioactivity in your body, so you remain safe to be around family and children.

The main ways radiation is delivered for parathyroid carcinoma:

Surgery

The primary and only reliably curative treatment — a complete, in-one-piece removal at the first operation, with re-operation used for recurrences.

Adjuvant radiation

External-beam radiation to the neck after surgery can lower the chance of local recurrence when the tumor was invasive, incompletely removed, or involved lymph nodes.

Palliative radiation

Targeted radiation can relieve pain from bone deposits or control a specific area of recurrent disease that cannot be removed surgically.

Latest studies shaping care

Care keeps improving — often toward getting the same excellent results with less burden on patients. A few developments:

First operation is the decisive one: Outcome studies repeatedly show that a complete en-bloc removal at the very first surgery — before the tumor is disturbed — gives the best chance of cure, while piecemeal or incomplete surgery sharply raises recurrence.[1]

Endocrine surgery outcome series (2020–2025)

Calcium control as a lifeline: Because dangerous high calcium, not tumor bulk, is often what threatens patients, drugs such as cinacalcet that lower PTH-driven calcium have become central to managing recurrent or metastatic disease and improving quality of life.[2]

Endocrinology treatment studies (2021–2025)

The role of adjuvant radiation: Series of high-risk, invasive, or incompletely removed tumors suggest that adding radiation to the neck after surgery can reduce local recurrence, supporting its selective use in these situations.[3]

Head-and-neck and endocrine oncology studies (2020–2024)

Common questions

Why is the high calcium such a big deal? Most parathyroid carcinomas pour out parathyroid hormone, which drives blood calcium very high. That high calcium — not the tumor pressing on something — causes most of the symptoms (kidney stones, bone pain, fatigue, confusion) and can be life-threatening, so controlling it is just as urgent as treating the tumor.

Why does the first surgery matter so much? The best chance of cure comes from removing the tumor completely, in one piece, with the surrounding tissue, at the very first operation. If the tumor is broken into or only partly removed, cancer cells can be left behind that are very hard to clear later, which is why this surgery is best done by an experienced endocrine surgeon.

Should I be tested for an inherited cause? Sometimes. A minority of parathyroid carcinomas are linked to an inherited condition (hyperparathyroidism-jaw tumor syndrome, tied to the CDC73 gene). Your team may recommend genetic counseling, especially if you are young or have a family history, so relatives can be screened if needed.

References

Numbered sources for the studies cited above. Links open the primary publication on PubMed or the publisher’s site.

  1. Endocrine surgery outcome series (2020–2025) (no indexed identifier — see your care team)
  2. Endocrinology treatment studies (2021–2025) (no indexed identifier — see your care team)
  3. Head-and-neck and endocrine oncology studies (2020–2024) (no indexed identifier — see your care team)
Medical disclaimer: This guide is general patient education, not medical advice, and reflects widely accepted standards as of 2026. Your situation is unique — always discuss your diagnosis and options with your own care team. CureRays clinicians are here to help you understand your choices.

Talk to a CureRays radiation oncologist Back to all guides